A NOVEL SCORE TO EVALUATE ABDOMINAL SYMPTOM IMPROVEMENT IN PATIENTS WITH CONSTIPATION-PREDOMINANT IBS DEMONSTRATES EFFICACY OF LINACLOTIDE FOR IMPROVING ABDOMINAL BLOATING, DISCOMFORT, AND PAIN IN A PHASE 3B TRIAL

Lin Chang  ¹     Brian Lacy  ²     Baharak Moshiree  ³     Amy Kassebaum  ⁴     Jessica L. Abel  ⁵     Jennifer Hanlon  ⁶     Wilmin P Bartolini  ⁶     Ramesh Boinpally  ⁷     Wieslaw Bochenek  ⁷     Susan Fox  ⁷     Madhuja Mallick  ⁷     Ken Tripp  ⁸     Nick Omniewski  ⁸     Elizabeth Shea  ⁸     Niels Borgstein  ^9    
1 David Geffen School of Medicine, Los Angeles, United States
² Mayo Clinic Hospital, Jacksonville, United States
³ Atrium Health, University of North Carolina, Charlotte, United States
⁴ Northwestern Memorial Hospital, Chicago, United States
⁵ AbbVie Inc., Jersey City, United States
⁶ Ironwood Pharmaceuticals Inc., Boston, United States
⁷ AbbVie Inc., Madison, United States
⁸ Cyclerion Therapeutics, Boston, United States
⁹ Ironwood Pharmaceuticals Inc., Cambridge, United States

Session
Other lower GI disorders (Posters)

Conference
UEG Week Virtual 2020

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)